Afya Ltd

Afya Ltd

  • Price (EUR)11.90
  • Today's Change-0.10 / -0.83%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 09 2023 20:40 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

  • Revenue in USD (TTM)506.79m
  • Net income in USD72.98m
  • Incorporated2019
  • Employees8.71k
  • Location
    Afya LtdAlameda Oscar NiemeyerNo 119, Sala 504 Vila Da SerraNova Lima 00000BrazilBRA
  • Phone+55 3 135157500
  • Websitehttps://www.afya.com.br/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AFYA:NSQ since
Sociedade De Educacao Tiradentes Sa-Educational Institutions(2)Announced13 Oct 202213 Oct 2022Announced-10.18%155.87m
Data delayed at least 15 minutes, as of Jun 09 2023 21:00 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.